NVO
Novo Nordisk
NVO
NVO
Delisted
NVO was delisted on the 15th of May, 2026.
1,236 hedge funds and large institutions have $11.9B invested in Novo Nordisk in 2026 Q1 according to their latest regulatory filings, with 142 funds opening new positions, 437 increasing their positions, 462 reducing their positions, and 258 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less call options, than puts
Call options by funds: $1.44B | Put options by funds: $2.14B
42% less funds holding in top 10
Funds holding in top 10: 19 → 11 (-8)
45% less first-time investments, than exits
New positions opened: 142 | Existing positions closed: 258
Holders
1,236
Holding in Top 10
11
Calls
$1.44B
Puts
$2.14B
Top Buyers
| 1 | +$916M | |
| 2 | +$468M | |
| 3 | +$371M | |
| 4 |
Two Sigma Investments
New York
|
+$282M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$237M |
Top Sellers
| 1 | -$411M | |
| 2 | -$278M | |
| 3 | -$248M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$245M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$221M |
